Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Ionis Pharmaceuticals, Inc. develops six marketed medicines for serious diseases, including medicines for neurologic and cardiovascular diseases. Its marketed medicines consist of TRYNGOLZA, WAINUA (eplontersen), SPINRAZA (nusinersen), QALSODY (tofersen), TEGSEDI (inotersen) and WAYLIVRA (volanesorsen). TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS). WAINUA is approved for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults. SPINRAZA is used for the treatment of pediatric and adult patients with spinal muscular atrophy. QALSODY is approved for the treatment of Amyotrophic Lateral Sclerosis in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene, or SOD1-ALS. TEGSEDI is approved for the treatment of ATTRv-PN in adults. WAYLIVRA is approved as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk of acute, potentially fatal pancreatitis.
Find out what a historical investment in Ionis Pharmaceuticals, Inc. would be worth today using our IONS stock calculator.
Buying IONS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Ionis Pharmaceuticals, Inc. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in IONS
What is the ticker symbol of Ionis Pharmaceuticals, Inc.?
The ticker symbol for Ionis Pharmaceuticals, Inc. is IONS.
How much is one share of IONS?
One share of IONS is valued at $27.09 as of 20 November 2026.
What is the market capitalisation of Ionis Pharmaceuticals, Inc. IONS?
As of 20 November 2026 Ionis Pharmaceuticals, Inc. has a market cap of $4.53B.
What is the 52-week high for Ionis Pharmaceuticals, Inc. stock?
The Ionis Pharmaceuticals, Inc. 52-week high stock price is $86.74.
What is the 52-week low for Ionis Pharmaceuticals, Inc. stock?
The Ionis Pharmaceuticals, Inc. 52-week low stock price is $26.55.
Can I buy IONS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IONS shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IONS on Stake
Buy IONS from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of IONS from only US$10 with fractional shares